Radujković, A., Dietrich, S., Andrulis, M., Longerich, T., Nanda, K., Giese, T., . . . Luft, T. (2016). Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy. International journal of cancer, 139(6), . https://doi.org/10.1002/ijc.30181
Chicago Style (17th ed.) CitationRadujković, Aleksandar, Sascha Dietrich, Mindaugas Andrulis, Thomas Longerich, Kriti Nanda, Thomas Giese, Anthony Dick Ho, Peter Dreger, and Thomas Luft. "Expression of CDKN1C in the Bone Marrow of Patients with Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Is Associated with Poor Survival After Conventional Chemotherapy." International Journal of Cancer 139, no. 6 (2016). https://doi.org/10.1002/ijc.30181.
MLA (9th ed.) CitationRadujković, Aleksandar, et al. "Expression of CDKN1C in the Bone Marrow of Patients with Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Is Associated with Poor Survival After Conventional Chemotherapy." International Journal of Cancer, vol. 139, no. 6, 2016, https://doi.org/10.1002/ijc.30181.